• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铁死亡:生物学及其在肝脏疾病中的作用

Ferroptosis: biology and role in liver disease.

作者信息

Hino Keisuke, Nishina Sohji, Yanatori Izumi

机构信息

Digestive Disease Center, Shunan Memorial Hospital, 1-10-1 Ikunoya-Minami, Kudamatsu, Yamaguchi, 744-0033, Japan.

Department of Gastroenterology and Hepatology, Kawasaki Medical School, Kurashiki, Japan.

出版信息

J Gastroenterol. 2025 Sep 18. doi: 10.1007/s00535-025-02300-5.

DOI:10.1007/s00535-025-02300-5
PMID:40965654
Abstract

Ferroptosis is a form of nonapoptotic cell death that is driven by iron-dependent lipid peroxidation and is relevant to a wide range of biological processes, such as development, aging, immunity, and cancer. Ferroptosis has also been linked to numerous hepatic metabolic pathways, including the metabolism of iron, fatty acids, and amino acids, such as cysteine. During the last decade, studies on the biology of and molecules regulating ferroptosis have shed light on the role of ferroptosis in liver disease and its implications. The susceptibility of liver cells to ferroptosis determines the extent of liver injury and affects the progression of nonneoplastic diseases, whereas liver cancer cells display intrinsic or acquired resistance to ferroptosis, which promotes cancer progression. These findings indicate that ferroptosis represents a promising target for the prevention and treatment of many forms of liver disease. In this review, we provide an update on the mechanisms regulating ferroptosis, focusing on the peroxidation of phospholipids, the antioxidant pathways that limit lipid peroxidation, and the regulation of the labile iron pool, all of which are closely connected. We also summarize the roles and importance of ferroptosis in the pathogenesis of liver disease, and the therapeutic potential of targeting ferroptosis in liver diseases.

摘要

铁死亡是一种非凋亡性细胞死亡形式,由铁依赖性脂质过氧化驱动,与多种生物学过程相关,如发育、衰老、免疫和癌症。铁死亡还与众多肝脏代谢途径有关,包括铁、脂肪酸和氨基酸(如半胱氨酸)的代谢。在过去十年中,关于铁死亡生物学和调节铁死亡分子的研究揭示了铁死亡在肝脏疾病中的作用及其影响。肝细胞对铁死亡的易感性决定了肝损伤的程度,并影响非肿瘤性疾病的进展,而肝癌细胞对铁死亡表现出内在或获得性抗性,这促进了癌症进展。这些发现表明,铁死亡是预防和治疗多种肝脏疾病的一个有前景的靶点。在本综述中,我们提供了关于调节铁死亡机制的最新进展,重点关注磷脂的过氧化、限制脂质过氧化的抗氧化途径以及不稳定铁池的调节,所有这些都紧密相连。我们还总结了铁死亡在肝脏疾病发病机制中的作用和重要性,以及针对肝脏疾病靶向铁死亡的治疗潜力。

相似文献

1
Ferroptosis: biology and role in liver disease.铁死亡:生物学及其在肝脏疾病中的作用
J Gastroenterol. 2025 Sep 18. doi: 10.1007/s00535-025-02300-5.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Programmed Cell Death of Chondrocytes, Synovial Cells, Osteoclasts, and Subchondral Bone Cells in Osteoarthritis.骨关节炎中软骨细胞、滑膜细胞、破骨细胞和软骨下骨细胞的程序性细胞死亡
J Inflamm Res. 2025 Sep 8;18:12323-12360. doi: 10.2147/JIR.S514309. eCollection 2025.
4
Targeting Ferroptosis With Natural Products to Treat Diabetes and Its Complications: Opportunities and Challenges.利用天然产物靶向铁死亡治疗糖尿病及其并发症:机遇与挑战
Phytother Res. 2025 Jul 9. doi: 10.1002/ptr.70028.
5
Ferroptosis and aging: Inducing and catalyzing neurodegenerative diseases.铁死亡与衰老:引发和催化神经退行性疾病。
Neural Regen Res. 2025 Sep 3. doi: 10.4103/NRR.NRR-D-25-00710.
6
Uncovering the role of ferroptosis in Bietti crystalline dystrophy and potential therapeutic strategies.揭示铁死亡在 Bietti 结晶样变性中的作用及潜在治疗策略。
Cell Commun Signal. 2024 Jul 11;22(1):359. doi: 10.1186/s12964-024-01710-x.
7
Ferroptosis and Nrf2 Signaling in Head and Neck Cancer: Resistance Mechanisms and Therapeutic Prospects.头颈癌中的铁死亡与Nrf2信号传导:耐药机制与治疗前景
Antioxidants (Basel). 2025 Aug 13;14(8):993. doi: 10.3390/antiox14080993.
8
Ferroptosis in health and disease.铁死亡在健康和疾病中的作用。
Redox Biol. 2024 Sep;75:103211. doi: 10.1016/j.redox.2024.103211. Epub 2024 May 30.
9
Short-Term Memory Impairment短期记忆障碍
10
Paclitaxel Attenuates Atherosclerosis by Suppressing Macrophage Ferroptosis and Improving Lipid Metabolism via the Sirt1/Nrf2/GPX4 Pathway.紫杉醇通过Sirt1/Nrf2/GPX4途径抑制巨噬细胞铁死亡和改善脂质代谢来减轻动脉粥样硬化。
FASEB J. 2025 Aug 15;39(15):e70917. doi: 10.1096/fj.202501047RR.

本文引用的文献

1
Cytosolic cytochrome c represses ferroptosis.胞质细胞色素c抑制铁死亡。
Cell Metab. 2025 Jun 3;37(6):1326-1343.e10. doi: 10.1016/j.cmet.2025.03.014. Epub 2025 Apr 14.
2
ALDH7A1 protects against ferroptosis by generating membrane NADH and regulating FSP1.醛脱氢酶7A1通过生成膜结合型烟酰胺腺嘌呤二核苷酸(NADH)并调节铁死亡抑制蛋白1(FSP1)来抵御铁死亡。
Cell. 2025 May 15;188(10):2569-2585.e20. doi: 10.1016/j.cell.2025.03.019. Epub 2025 Apr 14.
3
Lysosomal lipid peroxidation contributes to ferroptosis induction via lysosomal membrane permeabilization.
溶酶体脂质过氧化通过溶酶体膜通透性增加促进铁死亡诱导。
Nat Commun. 2025 Apr 15;16(1):3554. doi: 10.1038/s41467-025-58909-w.
4
The Impact of TP53-Induced Glycolysis and Apoptosis Regulator on Prognosis in Hepatocellular Carcinoma: Association with Tumor Microenvironment and Ferroptosis.TP53诱导的糖酵解和凋亡调节因子对肝细胞癌预后的影响:与肿瘤微环境和铁死亡的关联
Liver Cancer. 2024 Aug 12;14(1):36-57. doi: 10.1159/000540180. eCollection 2025 Mar.
5
Dicoumarol sensitizes hepatocellular carcinoma cells to ferroptosis induced by imidazole ketone erastin.双香豆素使肝癌细胞对咪唑酮埃拉斯汀诱导的铁死亡敏感。
Front Immunol. 2025 Feb 11;16:1531874. doi: 10.3389/fimmu.2025.1531874. eCollection 2025.
6
S100P is a ferroptosis suppressor to facilitate hepatocellular carcinoma development by rewiring lipid metabolism.S100P是一种铁死亡抑制因子,通过重塑脂质代谢促进肝细胞癌的发展。
Nat Commun. 2025 Jan 8;16(1):509. doi: 10.1038/s41467-024-55785-8.
7
PRDX6 contributes to selenocysteine metabolism and ferroptosis resistance.PRDX6有助于硒代半胱氨酸代谢和铁死亡抗性。
Mol Cell. 2024 Dec 5;84(23):4645-4659.e9. doi: 10.1016/j.molcel.2024.10.027. Epub 2024 Nov 14.
8
Heme oxygenase 1-mediated ferroptosis in Kupffer cells initiates liver injury during heat stroke.热射病期间,库普弗细胞中血红素加氧酶1介导的铁死亡引发肝损伤。
Acta Pharm Sin B. 2024 Sep;14(9):3983-4000. doi: 10.1016/j.apsb.2024.05.007. Epub 2024 May 13.
9
Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH.综合临床前研究确定 FerroTerminator1 是治疗 MASH 的有效药物。
Cell Metab. 2024 Oct 1;36(10):2190-2206.e5. doi: 10.1016/j.cmet.2024.07.013. Epub 2024 Aug 13.
10
Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease.铁死亡是代谢功能障碍相关脂肪性肝病中可靶向的有害因素。
Cell Death Differ. 2024 Sep;31(9):1113-1126. doi: 10.1038/s41418-024-01348-9. Epub 2024 Jul 26.